These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10550823)

  • 1. Principles of chemoradiation: theoretical and practical considerations.
    Herscher LL; Cook JA; Pacelli R; Pass HI; Russo A; Mitchell JB
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):11-22. PubMed ID: 10550823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.
    Kimple RJ
    Mol Interv; 2010 Dec; 10(6):341-53. PubMed ID: 21263160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.
    Pauwels B; Wouters A; Peeters M; Vermorken JB; Lardon F
    Future Oncol; 2010 Sep; 6(9):1485-96. PubMed ID: 20919831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
    Lee TK; Stupans I
    J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
    Lawrence YR; Vikram B; Dignam JJ; Chakravarti A; Machtay M; Freidlin B; Takebe N; Curran WJ; Bentzen SM; Okunieff P; Coleman CN; Dicker AP
    J Natl Cancer Inst; 2013 Jan; 105(1):11-24. PubMed ID: 23231975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and emerging radiosensitizers and radioprotectors.
    Spalding AC; Lawrence TS
    Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions.
    Bentzen SM; Harari PM; Bernier J
    Nat Clin Pract Oncol; 2007 Mar; 4(3):172-80. PubMed ID: 17327857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel radiation sensitizers targeting tissue hypoxia.
    Rowinsky EK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):61-70. PubMed ID: 10550828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxanes in combined-modality therapy for solid tumors.
    Choy H
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of amifostine as a radioprotector.
    Wasserman TH; Brizel DM
    Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of radiation response of prostatic carcinoma by lonidamine.
    Dudak SD; Lopez A; Block NL; Lokeshwar BL
    Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy and chemotherapy.
    Cancer; 1976 Apr; 37(4 Suppl):2093-107. PubMed ID: 769944
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of taxanes with radiation: preclinical studies.
    Milas L; Milas MM; Mason KA
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):12-26. PubMed ID: 10210536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
    Deutsch E; Soria JC; Armand JP
    Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule.
    Heravi M; Rachid Z; Goudarzi A; Schlisser A; Jean-Claude BJ; Radzioch D; Muanza TM
    Anticancer Drugs; 2009 Sep; 20(8):659-67. PubMed ID: 19581798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological basis for concomitant chemoradiotherapy in carcinomas].
    Favaudon V; Noël G
    Bull Cancer; 2005 Dec; 92(12):1027-31. PubMed ID: 16396748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
    Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
    Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting base excision repair as a sensitization strategy in radiotherapy.
    Vens C; Begg AC
    Semin Radiat Oncol; 2010 Oct; 20(4):241-9. PubMed ID: 20832016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL; Russell PJ; Knittel T; Milross C
    Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
    Goldstein M; Kastan MB
    Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.